Patents by Inventor Takuji Kouzuma
Takuji Kouzuma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20120129202Abstract: Compositions for accurately assaying a glycated protein by: 1) avoiding effects of globulin and ascorbic acid components, 2) stabilizing proteases and at least enzymes acting on glycated amino acids; 3) accurately assaying albumin; and 4) assaying glycated albumin while avoiding the effects of glycated hemoglobin, and an assay method are provided. Thus, the contents of a glycated protein and glycated albumin can be more accurately determined.Type: ApplicationFiled: December 9, 2011Publication date: May 24, 2012Inventors: Takuji Kouzuma, Issei Yoshioka, Motoo Arai, Junichi Sumitani, Shigeyuki Imamura
-
Patent number: 8105800Abstract: Composition for accurately assaying a glycated protein by: 1) avoiding effects of globulin and ascorbic acid components, 2) siabilizing proteases and at least enzymes acting on glycated amino acids; 3) accurately assaying albumin; and 4) assaying glycated albumin while avoiding the effects of glycated hemoglobin, and an assay method are provided. Thus, the contents of a glycated protein and glycated albumin can be more accurately determined.Type: GrantFiled: July 31, 2007Date of Patent: January 31, 2012Assignee: Asahi Kasei Pharma CorporationInventors: Takuji Kouzuma, Issei Yoshioka, Motoo Arai, Junichi Sumitani, Shigeyuki Imamura
-
Publication number: 20110312009Abstract: Compositions for accurately assaying a glycated protein by: 1) avoiding effects of globulin and ascorbic acid components, 2) stabilizing proteases and at least enzymes acting on glycated amino acids; 3) accurately assaying albumin; and 4) assaying glycated albumin while avoiding the effects of glycated hemoglobin, and an assay method are provided. Thus, the contents of a glycated protein and glycated albumin can be more accurately determined.Type: ApplicationFiled: July 31, 2007Publication date: December 22, 2011Inventors: Takuji Kouzuma, Issei Yoshioka, Motoo Arai, Junichi Sumitani, Shigeyuki Imamura
-
Patent number: 8080423Abstract: Stabilizers for colorants used for detection of enzymatic reactions, having a cyclodextrin and a catalase; reagents including stabilizers; and methods of use of such stabilizers and reagents.Type: GrantFiled: August 4, 2005Date of Patent: December 20, 2011Assignee: Asahi Kasei Pharma CorporationInventors: Takuji Kouzuma, Yoko Nagai, Shigeyuki Imamura
-
Patent number: 7943337Abstract: There is provided a method for specifically determining a glycated ?-chain N-terminal of glycated hemoglobin using enzymes without a separation operation, and a determination reagent kit therefor. A protease that cleaves a glycated amino acid and/or a glycated peptide from a glycated ?-chain N-terminal without substantially cleaving a glycated amino acid or a glycated peptide from a glycated ?-chain N-terminal of glycated hemoglobin or a fragment thereof is screened. The method of specifically determining a glycated ?-chain N-terminal of glycated hemoglobin and the determination reagent kit are provided by using the protease obtained by the screening method. According to the present invention, a glycated ?-chain N-terminal of glycated hemoglobin can specifically be determined without a separation operation.Type: GrantFiled: July 21, 2009Date of Patent: May 17, 2011Assignees: Asahi Kasei Pharma Corporation, Ichibiki Co., Ltd.Inventors: Takeshi Matsuoka, Shinji Koga, Takuji Kouzuma
-
Publication number: 20090317851Abstract: There is provided a method for specifically determining a glycated ?-chain N-terminal of glycated hemoglobin using enzymes without a separation operation, and a determination reagent kit therefor. A protease that cleaves a glycated amino acid and/or a glycated peptide from a glycated ?-chain N-terminal without substantially cleaving a glycated amino acid or a glycated peptide from a glycated ?-chain N-terminal of glycated hemoglobin or a fragment thereof is screened. The method of specifically determining a glycated ?-chain N-terminal of glycated hemoglobin and the determination reagent kit are provided by using the protease obtained by the screening method. According to the present invention, a glycated ?-chain N-terminal of glycated hemoglobin can specifically be determined without a separation operation.Type: ApplicationFiled: July 21, 2009Publication date: December 24, 2009Applicants: ASAHI KASEI PHARMA CORPORATION, ICHIBIKI CO., LTD.Inventors: TAKESHI MATSUOKA, SHINJI KOGA, TAKUJI KOUZUMA
-
Patent number: 7588910Abstract: There is provided a method for specifically determining a glycated ?-chain N-terminal of glycated hemoglobin using enzymes without a separation operation, and a determination reagent kit therefor. A protease that cleaves a glycated amino acid and/or a glycated peptide from a glycated ?-chain N-terminal without substantially cleaving a glycated amino acid or a glycated peptide from a glycated ?-chain N-terminal of glycated hemoglobin or a fragment thereof is screened. The method of specifically determining a glycated ?-chain N-terminal of glycated hemoglobin and the determination reagent kit are provided by using the protease obtained by the screening method. According to the present invention, a glycated ?-chain N-terminal of glycated hemoglobin can specifically be determined without a separation operation.Type: GrantFiled: May 21, 2004Date of Patent: September 15, 2009Assignees: Asahi Kasei Pharma Corporation, Ichibiki Co., Ltd.Inventors: Takeshi Matsuoka, Shinji Koga, Takuji Kouzuma, Issei Yoshioka, Atsuhisa Nishimura, Homare Itou, Toshihiko Kumazawa, Takashi Kuroyanagi
-
Publication number: 20090042279Abstract: It is intended to provide a noninvasive method of conveniently detecting mild impaired glucose tolerance and/or insulin hyposecretion at the early stage with the use of an enzyme. Namely, mild impaired glucose tolerance and/or insulin hyposecretion at the early stage are detected by quantifying myoinositol secreted into the urine before loading glucose and after loading glucose for a definite period of time with the use of a reagent and comparing the increase (or the increase ratio) in the myoinositol content thus measured with a characteristic level which has been preliminarily determined in normal subjects.Type: ApplicationFiled: October 9, 2008Publication date: February 12, 2009Applicant: Asahi Kasei Pharma CorporationInventors: Masaru YAMAKOSHI, Takuji Kouzuma
-
Patent number: 7452687Abstract: It is intended to provide a noninvasive method of conveniently detecting mild impaired glucose tolerance and/or insulin hyposecretion at the early stage with the use of an enzyme. Namely, mild impaired glucose tolerance and/or hyposecretion at the early stage are detected by quantifying myoinositol secreted into the urine before loading glucose and after loading glucose for a definite period of time with the use of a reagent and comparing the increase (or the increase ratio) in the myoinositol content thus measured with a characteristic level which has been preliminarily determined in normal subjects.Type: GrantFiled: March 27, 2003Date of Patent: November 18, 2008Assignee: Asahi Kasei Pharma CorporationInventors: Masaru Yamakoshi, Takuji Kouzuma
-
Publication number: 20080113381Abstract: There is provided a method for specifically determining a glycated ?-chain N-terminal of glycated hemoglobin using enzymes without a separation operation, and a determination reagent kit therefor. A protease that cleaves a glycated amino acid and/or a glycated peptide from a glycated ?-chain N-terminal without substantially cleaving a glycated amino acid or a glycated peptide from a glycated ?-chain N-terminal of glycated hemoglobin or a fragment thereof is screened. The method of specifically determining a glycated ?-chain N-terminal of glycated hemoglobin and the determination reagent kit are provided by using the protease obtained by the screening method. According to the present invention, a glycated ?-chain N-terminal of glycated hemoglobin can specifically be determined without a separation operation.Type: ApplicationFiled: May 21, 2004Publication date: May 15, 2008Inventors: Takeshi Matsuoka, Shinji Koga, Takuji Kouzuma, Issei Yoshioka, Atsuhisa Nishimura, Homare Itou, Toshihiko Kumazawa, Takashi Kuroyanagi
-
Publication number: 20070224685Abstract: Provided are: a protease reaction promoter which is superior in usefulness to the known protease reaction promoters; a stabilizer for a colorant used for detection of an enzymatic reaction, and a method of stabilizing the colorant; and a reagent for and a method of measuring a glycated protein and a ratio of a glycated protein using the same.Type: ApplicationFiled: August 4, 2005Publication date: September 27, 2007Applicant: ASAHI KASEI PHARMA CORPORATIONInventors: Takuji Kouzuma, Yoko Nagai, Shigeyuki Imamura
-
Patent number: 7250269Abstract: Compositions for accurately assaying a glycated protein by: 1) avoiding effects of globulin and ascorbic acid components, 2) siabilizing proteases and at least enzymes acting on glycated amino acids; 3) accurately assaying albumin; and 4) assaying glycated albumin while avoiding the effects of glycated hemoglobin, and an assay method are provided. Thus, the contents of a glycated protein and glycated albumin can be more accurately determined.Type: GrantFiled: January 30, 2002Date of Patent: July 31, 2007Assignee: Asahi Kasei Pharma CorporationInventors: Takuji Kouzuma, Issei Yoshioka, Motoo Arai, Junichi Sumitani, Shigeyuki Imamura
-
Publication number: 20050214885Abstract: It is intended to provide a noninvasive method of conveniently detecting mild impaired glucose tolerance and/or insulin hyposecretion at the early stage with the use of an enzyme. Namely, mild impaired glucose tolerance and/or hyposecretion at the early stage are detected by quantifying myoinositol secreted into the urine before loading glucose and after loading glucose for a definite period of time with the use of a reagent and comparing the increase (or the increase ratio) in the myoinositol content thus measured with a characteristic level which has been preliminarily determined in normal subjects.Type: ApplicationFiled: March 27, 2003Publication date: September 29, 2005Applicant: Asahi Kasei Pharma CorporationInventors: Masaru Yamakoshi, Takuji Kouzuma
-
Publication number: 20050101771Abstract: Compositions for accurately assaying a glycated protein by: 1) avoiding effects of globulin and ascorbic acid components, 2) siabilizing proteases and at least enzymes acting on glycated amino acids; 3) accurately assaying albumin; and 4) assaying glycated albumin while avoiding the effects of glycated hemoglobin, and an assay method are provided. Thus, the contents of a glycated protein and glycated albumin can be more accurately determined.Type: ApplicationFiled: January 30, 2002Publication date: May 12, 2005Inventors: Takuji Kouzuma, Issei Yoshioka, Motoo Arai, Junichi Sumitani, Shigeyuki Imamura